Mark D. Myslinski
Director Ejecutivo en CytoVas LLC .
Perfil
Mark D.
Myslinski currently works at CytoVas LLC, as Chief Executive Officer & Director.
Mr. Myslinski also formerly worked at Rapid Pathogen Screening, Inc., as President & Chief Executive Officer, Redpath Partners, Inc., as President & Chief Executive Officer, Interscope Technologies, Inc., as President & Chief Executive Officer, Helomics Corp., as Chief Executive Officer, MDxHealth SA, as Independent Non-Executive Director from 2012 to 2015, Hologic, Inc., as Senior Vice President & GM-Diagnostics, Johnson & Johnson, as Vice President-Ortho Clinical Diagnostics Unit in 2013, Veridex LLC, as Vice President & General Manager from 2011 to 2013, Saladax Biomedical, Inc., as Senior Vice President & Chief Commercial Officer in 2013, Ortho-Clinical Diagnostics, Inc., as Vice President, and Kew, Inc., as Chief Commercial Officer.
Mr. Myslinski received his undergraduate degree from Moravian College and Masters Business Admin degree from The Ohio University.
Cargos activos de Mark D. Myslinski
| Empresas | Cargo | Inicio |
|---|---|---|
CytoVas LLC
 CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | Director Ejecutivo | - |
Antiguos cargos conocidos de Mark D. Myslinski.
| Empresas | Cargo | Fin |
|---|---|---|
| MDXHEALTH SA | Director/Miembro de la Junta | 05/10/2015 |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Saladax Biomedical, Inc.
 Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Director de Operaciones | 12/03/2013 |
Rapid Pathogen Screening, Inc.
 Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Presidente | - |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Corporate Officer/Principal | - |
Formación de Mark D. Myslinski.
| Moravian College | Undergraduate Degree |
| The Ohio University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| HOLOGIC, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| MDXHEALTH SA | Health Technology |
| Empresas privadas | 9 |
|---|---|
Rapid Pathogen Screening, Inc.
Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Health Services |
Redpath Partners, Inc.
 Redpath Partners, Inc. Medical/Nursing ServicesHealth Services Redpath Partners, Inc. provides complex cancer diagnostic testing for pathologists, oncologists and clinicians. The company was founded by Del Mary Brady and Sydney D. Finkelstein and is headquartered in Pittsburgh, PA. | Health Services |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Health Technology |
Saladax Biomedical, Inc.
Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Commercial Services |
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |
Interscope Technologies, Inc.
 Interscope Technologies, Inc. Medical/Nursing ServicesHealth Services Interscope Technologies, Inc. provided services in high speed imaging systems for tissue and microarray slides. The company was headquartered in Allegheny, PA. | Health Services |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Health Services |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Health Services |
CytoVas LLC
CytoVas LLC Data Processing ServicesTechnology Services CytoVas LLC develops informatics platform that provides information on novel cellular markers of disease progression and individual treatment response to clinicians and drug developers. The firm's platforms include Cloud Cytomics and CytoVas Vascular Health Profile. Cloud Cytomics provides automated data collection, mining, and modeling solutions to clinical researchers. CytoVas Vascular Health Profile provides cytometric vascular health event detection test for clinical studies. The company was founded by Emile Mohler, III, Jonni Moore and Wade Rogers and is headquartered in Philadelphia, PA. | Technology Services |
- Bolsa de valores
- Insiders
- Mark D. Myslinski